Document is current
Any future updates will be listed below
-
Authors
Mouri, Atsuto
Kaira, Kyoichi
Yamaguchi, Ou
Shiono, Ayako
Miura, Yu
Hashimoto, Kosuke
Yamasaki, Satoshi
Nishihara, Fuyumi
Imai, Hisao
Kobayashi, Kunihiko
Kagamu, Hiroshi
- License Information
-
More Information
Article History
Received: 5 February 2025
Accepted: 7 June 2025
First Online: 12 July 2025
Declarations
:
: Atsuto Mouri reports personal fees from Chugai Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., Bristol-Myers Squibb Co., and Eli Lilly Japan K.K. Kyoichi Kaira reports personal fees from Astra-Zeneca K.K., Boehringer Ingelheim Japan Inc., Chugai Pharmaceutical Co., Ono Pharmaceutical Co. Ltd., and Bristol-Myers Squibb Co. Ltd and received grants from Astra-Zeneca K.K., Daiichi Sankyo Co, and Eli Lilly Japan K.K. Kunihiko Kobayashi reports personal fees from Daiichi Sankyo Co, Astra-Zeneca K.K., and Takeda Pharmaceuticals Co. Ltd. Kagamu Hiroshi reports personal fees from Astra-Zeneca K.K., Chugai Pharmaceutical Co., Ono Pharmaceutical Co. Ltd., and Bristol-Myers Squibb Co., Science Advisory; ImmuniT Reseaech. and receiving grants from Boehringer Ingelheim Japan Inc. and stocks or ownership interests from I mmuniT Research Inc., and Chemokine Technology Inc. The other authors have no conflicts of interest to declare.
